AbbVie Inc. (ABBV)
| Previous Close | 162.73 |
| Open | 164.41 |
| Bid | 162.50 x 1200 |
| Ask | 162.46 x 1000 |
| Day's Range | 161.99 - 163.99 |
| 52 Week Range | 130.96 - 182.89 |
| Volume | |
| Avg. Volume | 5,695,118 |
| Market Cap | 287.166B |
| Beta (5Y Monthly) | 0.56 |
| PE Ratio (TTM) | 48.54 |
| EPS (TTM) | 3.35 |
| Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | 6.20 (3.81%) |
| Ex-Dividend Date | Apr 12, 2024 |
| 1y Target Est | 183.20 |
Zacks3 Top Dividend Stocks to Maximize Your Retirement Income
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Insider Monkey10 Best May Dividend Stocks To Buy
In this article, we discuss 10 best May dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their past performance, and go directly to read 5 Best May Dividend Stocks To Buy. We are nearly halfway through 2024 and the market is showing stable performance. Though the S&P 500 fell […]
PR NewswireAbbVie to Present at the Bank of America Securities Healthcare Conference
AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., senior vice president, chief medical officer, global therapeutics, will present at 12:40 p.m. Central time.
